Entia Biosciences, Inc. (ERGO)
OTCMKTS · Delayed Price · Currency is USD
0.0008
+0.0006 (300.00%)
At close: Aug 20, 2026
Entia Biosciences Market Cap
Entia Biosciences has a market cap or net worth of $27.25 thousand as of September 10, 2026. Its market cap has increased by 700.03% in one year.
Market Cap
27.25K
Enterprise Value
n/a
Revenue
265.47K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since January 18, 2008, Entia Biosciences's market cap has decreased from 3.26M to 27.25K, a decrease of -99.16%. That is a compound annual growth rate of -22.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 27.25K | 166.68% |
| Dec 31, 2025 | 10.22K | 50.00% |
| Dec 13, 2024 | 6.81K | - |
| Dec 27, 2022 | 6.81K | -86.67% |
| Dec 31, 2021 | 51.09K | -88.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nascent Biotech | 51.85K |
| Itoco | 42.82K |
| Carisma Therapeutics | 29.29K |
| Nymox Pharmaceutical | 21.01K |
| Health Sciences Group | 20.51K |
| Scopus BioPharma | 16.83K |
| Regenicin | 15.35K |
| Statera Biopharma | 14.52K |